Surface Treatment of the Dental Implant with Hyaluronic Acid: An Overview of Recent Data.
Gabriele CervinoAgron MetoLuca FiorilloAlessandra OdoriciAida MetoCesare D'AmicoGiacomo OteriMarco Cicciu'Published in: International journal of environmental research and public health (2021)
Recently, interest has grown by focusing on the evaluation of a molecule already produced in the human body such as hyaluronic acid (HA), as an application to the surface of the titanium implant. Its osteo-conductive characteristics and positive interaction with the progenitor cells responsible for bone formation, consequently, make it responsible for secondary stability. The aim of this work was to analyze the various surface treatments in titanium implants, demonstrating that the topography and surface chemistry of biomaterials can correlate with the host response; also focusing on the addition of HA to the implant surface and assessing the biological implications during early stages of recovery. Used as a coating, HA acts on the migration, adhesion, proliferation and differentiation of cell precursors on titanium implants by improving the connection between implant and bone. Furthermore, the improvement of the bioactivity of the implant surfaces through HA could therefore facilitate the positioning of the dental prosthesis precisely in the early loading phase, thus satisfying the patients' requests. It is important to note that all the findings should be supported by further experimental studies in animals as well as humans to evaluate and confirm the use of HA in any field of dentistry.
Keyphrases
- hyaluronic acid
- soft tissue
- end stage renal disease
- ejection fraction
- chronic kidney disease
- endothelial cells
- escherichia coli
- newly diagnosed
- signaling pathway
- single cell
- mesenchymal stem cells
- staphylococcus aureus
- peritoneal dialysis
- biofilm formation
- prognostic factors
- patient reported outcomes
- electronic health record
- bone marrow
- induced pluripotent stem cells
- bone regeneration
- bone loss
- candida albicans
- replacement therapy